Paper535129
The multiplication of analogs, the best strategy for rapid extension of the oncostatic arsenal. How can they be compared experimentally?
Mathé G and 1 other. Cancer Chemother Pharmacol, 1979. Cited by 6 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. The multiplication of analogs, the best strategy for rapid extension of the oncostatic arsenal. How can they be compared experimentally? Papers, record 535129. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/535129
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The multiplication of analogs, the best strategy for rapid extension of the oncostatic arsenal. How can they be compared experimentally?
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Agents | Major topic |
| Animals | |
| Chemical and Drug Induced Liver Injury | |
| Drug Evaluation, Preclinical | |
| Drug Resistance | |
| Hematopoietic System | |
| Humans | |
| Lethal Dose 50 |
Source PubMed
References20
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 4,531,039 | A new antitumoral agent: 9-hydroxyellipticine. Possibility of a rational design of anticancerous drugs in the series of DNA intercalating drugs. | Proc Natl Acad Sci U S A | 1974 | https://conductscience.org/library/papers/4531039 | PubMed |
| 2 | 189,368 | Cancer chemotherapy: its role in the treatment strategy of hematologic malignancies and solid tumors. | Recent Results Cancer Res | 1976 | https://conductscience.org/library/papers/189368 | PubMed |
| 3 | 6,160,600 | A review of clinical studies of pepleomycin. | Recent Results Cancer Res | 1980 | https://conductscience.org/library/papers/6160600 | PubMed |
| 4 | 1,222,217 | The oncostatic and immunosuppressive action of new nitrosourea derivatives containing sugar radicals. | Biomedicine | 1975 | https://conductscience.org/library/papers/1222217 | PubMed |
| 5 | 4,164,182 | The growth of mouse bone marrow cells in vitro. | Aust J Exp Biol Med Sci | 1966 | https://conductscience.org/library/papers/4164182 | PubMed |
| 6 | 455,329 | Electron microscopic studies of the heart and light microscopic studies of the skin after treatment of golden hamsters with adriamycin, detorubicin, AD-32, and aclacinomycin. | Cancer Treat Rep | 1979 | https://conductscience.org/library/papers/455329 | PubMed |
| 7 | 5,909,159 | [The symptomatic treatment of agranulocytosis by leukocyte transfusion]. | Presse Med (1893) | 1966 | https://conductscience.org/library/papers/5909159 | PubMed |
| 8 | 123,170 | Chlorozotocin, 2-(3-(2-chloroethyl)-3-nitrosoureido)-D-glucopyranose, an antitumor agent with modified bone marrow toxicity. | Cancer Res | 1975 | https://conductscience.org/library/papers/123170 | PubMed |
| 9 | 7,444,146 | Clinical correlations of drug sensitivity in the human tumor stem cell assay. | Recent Results Cancer Res | 1980 | https://conductscience.org/library/papers/7444146 | PubMed |
| 10 | 274,996 | Phase II clinical trial with vindesine for remission induction in acute leukemia, blastic crisis of chronic myeloid leukemia, lymphosarcoma, and hodgkin's disease: absence of cross-resistance with vincristine. | Cancer Treat Rep | 1978 | https://conductscience.org/library/papers/274996 | PubMed |
| 11 | 7,444,141 | Ultrastructural study of the cardiotoxicity and light-microscopic findings of the skin after treatment of golden hamsters with seven different anthracyclines. | Recent Results Cancer Res | 1980 | https://conductscience.org/library/papers/7444141 | PubMed |
| 12 | 161,207 | Comparative pharmacology of three new nitrosourea analogues: RFCNU, RPCNU, and chlorozotocin. I. Oncostatic effects in mice. | Cancer Chemother Pharmacol | 1979 | https://conductscience.org/library/papers/161207 | PubMed |
| 13 | 4,534,200 | Quantitation of haemopoietic cells from normal and leukaemic RFM mice using an in vivo colony assay. | Br J Cancer | 1974 | https://conductscience.org/library/papers/4534200 | PubMed |
| 14 | 13,776,896 | A direct measurement of the radiation sensitivity of normal mouse bone marrow cells. | Radiat Res | 1961 | https://conductscience.org/library/papers/13776896 | PubMed |
| 15 | 342,260 | Simultaneous assay by six methods of the effect on haemopoietic precursor cells of adriamycin, methyl CCNU, 60Co gamma-rays, vinblastine, and cytosine arabinoside. | Exp Hematol | 1978 | https://conductscience.org/library/papers/342260 | PubMed |
| 16 | 7,444,137 | Preclinical and phase I studies of malonatoplatinum. | Recent Results Cancer Res | 1980 | https://conductscience.org/library/papers/7444137 | PubMed |
| 17 | 455,580 | Vindesine international workshop, Frankfurt, Germany, July 7, 1978. | Cancer Chemother Pharmacol | 1979 | https://conductscience.org/library/papers/455580 | PubMed |
| 18 | 4,886,629 | Pathogen-free isolation unit--three years' experience. | Br Med J | 1969 | https://conductscience.org/library/papers/4886629 | PubMed |
| 19 | 304,590 | Effectiveness of murine leukemia chemotherapy according to the immune state: reconsideration of correlations between chemotherapy, tumour cell killing, and survival time. | Recent Results Cancer Res | 1977 | https://conductscience.org/library/papers/304590 | PubMed |
| 20 | 884,687 | Lack of cross-resistance between certain platinum coordination compounds in mouse leukemia. | Cancer Res | 1977 | https://conductscience.org/library/papers/884687 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 3,801,787 | Cytostatic action of two nitrosoureas derived from cysteamine. | Br J Pharmacol | 1986 | https://conductscience.org/library/papers/3801787 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/535129
GET https://conductscience.org/api/papers/v1/535129/authors